| NCT ID | NCT05164328 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Athlete Heart |
| Study Type | OBSERVATIONAL |
| Enrollment | 450 participants |
| Start Date | 2015-06-23 |
| Primary Completion | 2035-06-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 450 participants in total. It began in 2015-06-23 with a primary completion date of 2035-06-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Pro@Heart (Prospective Athlete's Heart) study is an international multicentre long-term prospective trial. The primary objective of the Pro@Heart study is to investigate the impact of training load (i.e. accurately evaluated in term of type, frequency, duration and intensity) and genotype on the variability of structural, functional and electrical exercise induced cardiac remodeling (EICR) in young competitive endurance athletes. The second objective is to determine how EICR, training load and genotype are associated with physical performance, health benefits and cardiac pathology (e.g. exercise-related cardiomyopathies and arrhythmias) during follow-up over several decades.
Eligibility Criteria
Inclusion Criteria: 1. Males and females aged 14-23 years old 2. Athletes competing in endurance sports at national or international level for at least 2 years. Sports include: 1. Triathlon 2. Cycling 3. Distance running (≥ 1500 meters) 4. Rowing 5. Swimming 3. Non athletes engaged in \< 3 hours per week of physical activity Exclusion Criteria: 1. Medical history of cardiovascular disease 2. Current smoker of past history of smoking 3. Diabetes mellitus
Contact & Investigator
Guido Claessen, Prof. Dr.
✉ guido.claessen@uzleuven.beGuido Claessen, Prof. Dr.
STUDY CHAIR
UZ Leuven
Frequently Asked Questions
Who can join the NCT05164328 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, up to 23 Years, studying Athlete Heart. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05164328 currently recruiting?
Yes, NCT05164328 is actively recruiting participants. Contact the research team at guido.claessen@uzleuven.be for enrollment information.
Where is the NCT05164328 trial being conducted?
This trial is being conducted at Melbourne, Australia, Edegem, Belgium, Hasselt, Belgium, Leuven, Belgium.
Who is sponsoring the NCT05164328 clinical trial?
NCT05164328 is sponsored by Universitaire Ziekenhuizen KU Leuven. The principal investigator is Guido Claessen, Prof. Dr. at UZ Leuven. The trial plans to enroll 450 participants.